期刊文献+

潍坊市44 578例胎儿无创产前检测结果的回顾性分析 被引量:3

Retrospective analysis of 44578 pregnancies undergoing non-invasive prenatal testing in Weifang
原文传递
导出
摘要 目的回顾通过无创产前检测(non-invasive prenatal testing,NIPT)筛查21三体(trisomy 21,T21)、18三体(trisomy 18,T18)、13三体(trisomy 13,T13)以及性染色体和其他染色体的数目异常和>5 Mb的拷贝数变异的结果。方法对44578例孕妇进行NIPT检测,对提示为高风险者采集羊水或脐血样本,进行G显带染色体核型分析,并随访妊娠的结局。结果在44578例孕妇中,有466例(1.05%)NIPT检测提示为T21(n=1359)、T18(n=178)或T13(n=129)高风险,分别对其中301例、53例和20例进行羊水或脐血染色体检查,共确诊289(96.01%)例T21,40(75.47%)例T18,4(20.00%)例T13。NIPT检测未提示高风险的孕妇中,有2例胎儿出生后被诊断为唐氏综合征,未记录到18三体、13三体综合征。通过统计43552例记录胎儿核型检查结果或妊娠结局的孕妇的检查资料,NIPT检测的灵敏度和特异性分别为T21(99.31%,99.97%)、T18(100%,99.97%)、T13(100%,99.96%)。NIPT检测T21、T18、T13的阳性预测值分别为96.01%、75.47%、20.00%。结论与传统的唐筛和侵入性产前诊断相比,NIPT检测T21、T18和T13具有很高的灵敏度和特异性,是筛查胎儿染色体异常的最佳手段。 Objective To review the results of non-invasive prenatal testing(NIPT)for trisomy 21(T21),trisomy 18(T18),trisomy 13(T13),numerical aberration of sex and other autosomes and copy number variations with a size of>5 Mb.Methods NIPT was carried out for 44578 pregnant women.For those with a high-risk by NIPT,amniotic fluid or cord blood samples were collected for G-banding karyotype analysis,and the pregnancy outcome was followed up.Results Among the 44578 pregnant women,466(1.05%)were diagnosed as high risk of T21(n=1359),T18(n=178)or T13(n=129).Among these,301,53 and 20 were subjected to prenatal diagnosis by amniocyte or umbilical blood karyotyping analysis,among which 289 were diagnosed as T21,40(75.47%)as T18,and 4(20.00%)as T13.Among the high-risk pregnant women,2 cases were diagnosed as Down syndrome after birth,while no trisomy 18 and trisomy 13 were recorded.The sensitivity and specificity of NIPT were T21(99.31%,99.97%),T18(100%,99.97%),T13(100%,99.96%),respectively.The positive predictive values for T21,T18 and T13 by NIPT were 96.01%,75.47%and 20.00%,respectively.Conclusion Compared with conventional serological screening and invasive prenatal diagnosis,NIPT has a high sensitivity and specificity for T21,T18 and T13,and has provided an ideal method to screen fetal chromosomal abnormalities.
作者 徐红 Xu Hong(Weifang Family Planning Guidance Center,Shandong 261041,China)
出处 《中华医学遗传学杂志》 CAS CSCD 2020年第10期1065-1068,共4页 Chinese Journal of Medical Genetics
关键词 无创产前检测 血清学筛查 染色体异倍性 21三体 18三体 13三体 性染色体 Non-invasive prenatal testing Maternal serum screening Aneuploidy Trisomy 21 Trisomy 18 Trisomy 13 Sex chromosome
  • 相关文献

同被引文献25

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部